Conduct further clinical studies for UNI-494 in the U.S
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 15 Aug 2023
- Due
- 31 Dec 2024
- Delivered
- by 31 Dec 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“prepare to conduct further clinical studies in the U.S. in 2024”
What we found
Evidence strength A What the grades mean
The company confirmed in multiple filings that it completed a Phase I clinical study in healthy volunteers with UNI-494 during 2024, fulfilling its commitment to conduct further clinical studies.
-
A Unicycive Therapeutics, Inc. 10-K filed 2025-03-31
“As discussed herein, after completing IND enabling preclinical studies, we have completed a Phase I clinical study in healthy volunteers with UNI-494 in 2024.” ✓ confirmed on the page
Market reaction: the shares moved -12.2% against the S&P 500 over the three sessions around the disclosure (28 Mar 2025 to 2 Apr 2025). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Project other
- Indicative materiality
- Low rules
- Action
- Conduct
- Deliverable
- clinical studies for UNI-494
- Where
- U.S.
- In the company’s control
- Medium
- Specificity
- Medium
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Not met”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Unicycive Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-UNCY-002790 · Corrections policy